Sh2,000.00
Albendazol is a medication used for the treatment of a variety of:
| Settings | ALBENDAZOLE SYRP ALBASOL remove | Ascoril D syrup remove | Amoxyclav Spotcalv 625mg Tablets remove | Ampicillin Syrup remove | Amoxyclav 5ml Syrup remove | Infacare #1 remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh2,000.00 | Sh3,500.00 | Sh6,000.00 | Sh1,500.00 | Sh6,000.00 | Sh25,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description |
| |||||
| Content | Albendazol is a medication used for the treatment of a variety of:
| Ascoril D Plus Sugar Free Syrup 100 ml belongs to a class of medication called 'cough and cold preparations' primarily used to treat dry cough. Coughing (dry or productive) is the body's way of clearing irritants (like allergens, mucus or smoke) from airways and preventing infection. | Amoxicillin/clavulanic acid is a combination penicillin-type antibiotics used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu) | Ampicillin is a prescription penicillin-type antibiotic used to treat many different types of infections caused by bacteria, such as ear infections, bladder infections, pneumonia, gonorrhea, and E. coli or salmonella infection. | Amoxyclav DS Syrup is an antibiotic medicine that helps treat bacterial infections of the ear, nose, throat, chest, lungs, teeth, skin, and urinary tract. It is capable of killing bacteria that have become resistant to other therapies and thus also helps treat tuberculosis that is resistant to other treatments. | Infacare Stage 1 Infant Starter Formula is a powdered infant milk formula that’s been scientifically formulated to help with the optimal growth of your baby from birth up to 6 months. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.